Pancreatic Cancer Research

ResearcherUniversidade de São PauloNo recent work listed

Keli Lima

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-5498-7539; OpenAlex author ID A5059640215.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 1, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
2
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. The Multikinase Inhibitor AD80 Induces Mitotic Catastrophe and Autophagy in Pancreatic Cancer Cells. First author DOI 10.3390/cancers15153866↗
  2. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells. Co-author DOI 10.1007/s10637-022-01249-z↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. João Agostinho Machado-Neto · 2 shared papers, 2022–2023
  2. Jean Carlos Lipreri da Silva · 1 shared paper, 2022

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.